In collaboration with the Max Birnstiel Foundation, the Research Institute of Molecular Pathology (IMP) is seeking nominations for the inaugural International Birnstiel Award for Doctoral Research in Molecular Life Sciences. The objective of this award is to establish a community of outstanding talent in molecular life sciences and celebrate the research successes of young, up-and-coming scientists.
The International Birnstiel Awards for Doctoral Research in Molecular Life Sciences recognise the exceptional achievements of up to three PhD students in molecular life sciences from anywhere in the world. The awardees will attend the Vienna BioCenter PhD Symposium in Vienna (Austria) on 7 and 8 November 2019.
On this occasion, the awardees will present their work to an international audience of distinguished biologists and will each receive a trophy, certificate and cash prize of 2,000 euros. In addition, all travel and accommodation expenses of the awardees for the symposium will be covered.
Nominee profile and selection
The International Birnstiel Award targets doctoral students at an advanced stage of their PhD research who have contributed to make an outstanding discovery in their field. The selection committee comprises four senior scientists, three faculty members of IMP and one representative from the Max Birnstiel Foundation.
The selection committee will base its evaluation on the nomination materials and any relevant publications provided. Committee members will evaluate the application materials according to their scientific quality, originality and impact in molecular life sciences – in line with the legacy of Max Birnstiel and the tradition of IMP.
Eligibility and nominations
Only one nomination may be submitted per department or programme. The nomination must be submitted via this website by an authorised person, typically a department chair or PhD programme manager.
Students who completed their PhD research at Austrian institutions are exempted from the Birnstiel Awards as they are eligible for other awards in Austria.
A nomination will comprise the nominee’s CV, a description of the PhD research project and one recommendation letter from the student’s supervisor. Detailed specifications - and as of mid-May the nomination form - are available here. Nominations can be submitted by 30 June 2019.
About Max Birnstiel and the foundation
Max Luciano Birnstiel (12 July 1933 – 15 November 2014) was a molecular biologist and founding director of IMP with an internationally acclaimed research career. He was chair of the Institute of Molecular Biology at the University of Zurich (1972–1986) before becoming the founding director of IMP in Vienna. In this role, he made a major contribution to the exceptional academic standing of IMP. He retired from his post as Director in 1996.
Birnstiel’s research focused on gene regulation in eukaryotes. His lab was the first to purify single genes, the ribosomal RNA genes from the frog Xenopus laevis, in the late 1960s . Birnstiel was one of the first scientists to study how gene expression is regulated. He is also recognised for one of the earliest discoveries of a gene enhancer element, which his lab published in 1980 .
As a science manager, Birnstiel was a visionary who not only set IMP on track to achieving research excellence, but he was also a vital force behind raising the profile of the Vienna BioCenter, which is now one of Europe’s most dynamic life science hubs with four research institutes, three universities and two dozen biotech companies.
In 1993, Birnstiel initiated the collaboration between IMP and the University of Vienna that underpins the Vienna BioCenter International PhD Programme. Throughout his life, Max Birnstiel was a supporter of young talent and fostered an egalitarian culture at IMP. It was in this spirit that a foundation bearing his name was set up in 2018. The Max Birnstiel Foundation co-funds initiatives and activities that support young scientists in molecular life sciences.
The foundation’s initiatives include the International Birnstiel Award for doctoral research in molecular life sciences. First awarded in 2019, they will be presented at the 25-year anniversary symposium of the VBC PhD Programme next November. You can read more about Birnstiel's scientific legacy here.
Website of the Max Birnstiel Foundation